A

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

VP Global Trial Optimization

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeCambridge, MA, USA$301.8k - $408.2k

About the Job

Requirements

  • A master's degree of science, Master of Business Administration, Doctor of Philosophy, or equivalent in a relevant discipline is strongly preferred.
  • At least 20 years of industry experience focused on Clinical Operations, including global clinical trial conduct, feasibility, protocol optimization, patient recruitment and retention, and working with global contract research organizations.
  • At least 10 years of team leadership experience, building strong feasibility and patient recruitment teams.
  • Thorough understanding of clinical trial feasibility and scenario planning, including experience with supportive tools and technologies and Monte Carlo simulations, and proven experience in data analysis and interpretation to drive informed decision-making.
  • Thorough understanding of processes associated with feasibility, protocol optimization, site identification, patient recruitment, and retention.
  • Extensive experience in patient recruitment campaigns.
  • Demonstrated ability to deliver results and achieve objectives within budget and timeline constraints, with proven experience in cost optimization and reduction.
  • Extensive pharmaceutical or biotechnology experience and extensive knowledge of drug development processes, ICH-GCP guidelines, 21 CFR Part 11, and major Health Authority regulations as they pertain to operational aspects of clinical trials.
  • Comfort working with senior executive teams.
  • Well-networked with industry peers.
  • Strong project management skills and ability to lead effectively in a matrix organization and hold teams accountable to deliverables.
  • Ability to travel up to 30%.
  • Alignment with Alnylam Core Values: commitment to people, fierce innovation, purposeful sense of urgency, open culture, and passion for excellence.

Responsibilities

  • Drive a Feasibility Center of Excellence and partner with preferred contract research organizations to deliver data-driven, accurate, and optimal clinical trial scenario plans for country placement, enrollment rates, and study timelines; design and develop feasibility tools and processes.
  • Lead country placement discussions at Program Leadership Team meetings and outline country placement recommendations for clinical trials in support of business and trial needs; represent Clinical Operations at governance forums, including DevBoard, DOC, and PLT, as appropriate.
  • Lead protocol feasibility and scenario modeling and recommend optimized trial delivery strategies for country and site placement, enrollment rates, site identification, and trial milestones to inform decision-making at governance forums.
  • Oversee clinical trial enrollment modeling and identify the best path to clinical trial patients; model the impact of inclusion and exclusion criteria on enrollment potential and trial timelines.
  • Partner with study teams and contract research organizations to provide data-driven, accurate study timelines, milestones, and enrollment assumptions; lead clinical operations lock reviews and partner with study teams to communicate CLOCK milestones at governance forums.
  • Facilitate site identification and outline best-fit site archetypes.
  • Be accountable for predictable and consistent delivery of patient recruitment and retention strategies; lead identification and selection of portfolio-level recruitment strategies and sourcing, focusing on reducing patient burden and supporting diversity where appropriate.
  • Provide robust estimates of the impact of patient recruitment programs on trial enrollment and cost.
  • Identify and analyze important connections within and across therapeutic areas to optimize study planning and performance at the portfolio level.
  • Lead a team supporting all clinical trials across the portfolio.
  • Partner across functions to ensure studies are designed and delivered efficiently using data-driven insights and patient-centered approaches to accelerate clinical development and improve trial performance.

About the Company

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2002

Recently Posted Jobs

Explore more opportunities at Alnylam Pharmaceuticals

See more jobs